These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 37474228)

  • 1. Impact and cost-effectiveness of short-course tuberculosis preventive treatment for household contacts and people with HIV in 29 high-incidence countries: a modelling analysis.
    Ryckman T; Weiser J; Gombe M; Turner K; Soni P; Tarlton D; Mazhidova N; Churchyard G; Chaisson RE; Dowdy DW
    Lancet Glob Health; 2023 Aug; 11(8):e1205-e1216. PubMed ID: 37474228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of scaling up short course preventive therapy for tuberculosis among children across 12 countries.
    Jo Y; Gomes I; Flack J; Salazar-Austin N; Churchyard G; Chaisson RE; Dowdy DW
    EClinicalMedicine; 2021 Jan; 31():100707. PubMed ID: 33554088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis of interventions to improve diagnosis and preventive therapy for paediatric tuberculosis in 9 sub-Saharan African countries: A modelling study.
    Mafirakureva N; Mukherjee S; de Souza M; Kelly-Cirino C; Songane MJP; Cohn J; Lemaire JF; Casenghi M; Dodd PJ
    PLoS Med; 2023 Sep; 20(9):e1004285. PubMed ID: 37672524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness.
    Nsengiyumva NP; Campbell JR; Oxlade O; Vesga JF; Lienhardt C; Trajman A; Falzon D; Den Boon S; Arinaminpathy N; Schwartzman K
    PLoS Med; 2022 Jun; 19(6):e1004032. PubMed ID: 35696431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of community-based household tuberculosis contact management for children in Cameroon and Uganda: a modelling analysis of a cluster-randomised trial.
    Mafirakureva N; Tchounga BK; Mukherjee S; Tchakounte Youngui B; Ssekyanzi B; Simo L; Okello RF; Turyahabwe S; Kuate Kuate A; Cohn J; Vasiliu A; Casenghi M; Atwine D; Bonnet M; Dodd PJ
    Lancet Glob Health; 2023 Dec; 11(12):e1922-e1930. PubMed ID: 37918416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of a community-based approach for the investigation and management of children with household tuberculosis contact in Cameroon and Uganda: a cluster-randomised trial.
    Bonnet M; Vasiliu A; Tchounga BK; Cuer B; Fielding K; Ssekyanzi B; Tchakounte Youngui B; Cohn J; Dodd PJ; Tiendrebeogo G; Tchendjou P; Simo L; Okello RF; Kuate Kuate A; Turyahabwe S; Atwine D; Graham SM; Casenghi M;
    Lancet Glob Health; 2023 Dec; 11(12):e1911-e1921. PubMed ID: 37918417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis.
    Uppal A; Rahman S; Campbell JR; Oxlade O; Menzies D
    PLoS Med; 2021 Sep; 18(9):e1003712. PubMed ID: 34520463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing tuberculosis with community-based care in an HIV-endemic setting: a modelling analysis.
    Ross JM; Greene C; Broshkevitch CJ; Dowdy DW; van Heerden A; Heitner J; Rao DW; Roberts DA; Shapiro AE; Zabinsky ZB; Barnabas RV
    J Int AIDS Soc; 2024 Jun; 27(6):e26272. PubMed ID: 38861426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.
    Eaton JW; Menzies NA; Stover J; Cambiano V; Chindelevitch L; Cori A; Hontelez JA; Humair S; Kerr CC; Klein DJ; Mishra S; Mitchell KM; Nichols BE; Vickerman P; Bakker R; Bärnighausen T; Bershteyn A; Bloom DE; Boily MC; Chang ST; Cohen T; Dodd PJ; Fraser C; Gopalappa C; Lundgren J; Martin NK; Mikkelsen E; Mountain E; Pham QD; Pickles M; Phillips A; Platt L; Pretorius C; Prudden HJ; Salomon JA; van de Vijver DA; de Vlas SJ; Wagner BG; White RG; Wilson DP; Zhang L; Blandford J; Meyer-Rath G; Remme M; Revill P; Sangrujee N; Terris-Prestholt F; Doherty M; Shaffer N; Easterbrook PJ; Hirnschall G; Hallett TB
    Lancet Glob Health; 2014 Jan; 2(1):e23-34. PubMed ID: 25104632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness and health impact of screening and treatment of Mycobacterium tuberculosis infection among formerly incarcerated individuals in Brazil: a Markov modelling study.
    van Lieshout Titan A; Klaassen F; Pelissari DM; de Barros Silva JN; Alves K; Alves LC; Sanchez M; Bartholomay P; Johansen FDC; Croda J; Andrews JR; Castro MC; Cohen T; Vuik C; Menzies NA
    Lancet Glob Health; 2024 Sep; 12(9):e1446-e1455. PubMed ID: 39151980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.
    Marseille E; Kahn JG; Mmiro F; Guay L; Musoke P; Fowler MG; Jackson JB
    Lancet; 1999 Sep; 354(9181):803-9. PubMed ID: 10485721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scaling up integrated prevention campaigns for global health: costs and cost-effectiveness in 70 countries.
    Marseille E; Jiwani A; Raut A; Verguet S; Walson J; Kahn JG
    BMJ Open; 2014 Jun; 4(6):e003987. PubMed ID: 24969782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
    Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
    Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trial.
    Thomas R; Probert WJM; Sauter R; Mwenge L; Singh S; Kanema S; Vanqa N; Harper A; Burger R; Cori A; Pickles M; Bell-Mandla N; Yang B; Bwalya J; Phiri M; Shanaube K; Floyd S; Donnell D; Bock P; Ayles H; Fidler S; Hayes RJ; Fraser C; Hauck K;
    Lancet Glob Health; 2021 May; 9(5):e668-e680. PubMed ID: 33721566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-kind nutritional supplementation for household contacts of persons with tuberculosis would be cost-effective for reducing tuberculosis incidence and mortality in India: a modeling study.
    Sinha P; Dauphinais M; Carwile ME; Horsburgh CR; Menzies NA
    medRxiv; 2024 Jan; ():. PubMed ID: 38260435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of adding tuberculosis household contact investigation on passive case-finding strategy in Southwestern Uganda.
    Odongo D; Omech B; Acanga A
    PLoS One; 2023; 18(12):e0288761. PubMed ID: 38127969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Household contact investigation for the detection of tuberculosis in Vietnam: economic evaluation of a cluster-randomised trial.
    Lung T; Marks GB; Nhung NV; Anh NT; Hoa NLP; Anh LTN; Hoa NB; Britton WJ; Bestrashniy J; Jan S; Fox GJ
    Lancet Glob Health; 2019 Mar; 7(3):e376-e384. PubMed ID: 30784638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of a 12 country-intervention to scale up short course TB preventive therapy among people living with HIV.
    Shin H; Jo Y; Chaisson RE; Turner K; Churchyard G; Dowdy DW
    J Int AIDS Soc; 2020 Oct; 23(10):e25629. PubMed ID: 33107219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of interventions for HIV/AIDS, malaria, syphilis, and tuberculosis in 128 countries: a meta-regression analysis.
    Silke F; Earl L; Hsu J; Janko MM; Joffe J; Memetova A; Michael D; Zheng P; Aravkin A; Murray CJL; Weaver MR
    Lancet Glob Health; 2024 Jul; 12(7):e1159-e1173. PubMed ID: 38876762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of active case-finding of household contacts of pulmonary tuberculosis patients in a low HIV, tuberculosis-endemic urban area of Lima, Peru.
    Shah L; Rojas M; Mori O; Zamudio C; Kaufman JS; Otero L; Gotuzzo E; Seas C; Brewer TF
    Epidemiol Infect; 2017 Apr; 145(6):1107-1117. PubMed ID: 28162099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.